Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Sunday, February 28, 2021

Ipilimumab-nivolumab as first-line treatment in metastatic NSCLC

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2021 Feb 20:S0007-4551(21)00040-0. doi: 10.1016/j.bulcan.2021.01.005. Online ahead of print.

NO ABSTRACT

PMID:33622569 | DOI:10.1016/j.bulcan.2021.01.005

View on the web

No comments:

Post a Comment